Related references
Note: Only part of the references are listed.Long Non-coding RNA FOXD2-AS1 Promotes Proliferation, Migration, and Invasion in Cholangiocarcinoma Through Regulating miR-760/E2F3 Axis
Zengtao Hu et al.
DIGESTIVE DISEASES AND SCIENCES (2022)
LncRNA SBF2-AS1: A Budding Star in Various Cancers
Fangshun Tan et al.
CURRENT PHARMACEUTICAL DESIGN (2022)
Copper-induced cell death Excess copper causes mitochondrial protein aggregation and triggers a distinct form of cell death
Martha A. Kahison et al.
SCIENCE (2022)
Copper induces cell death by targeting lipoylated TCA cycle proteins
Peter Tsvetkov et al.
SCIENCE (2022)
LINC02154 promotes the proliferation and metastasis of hepatocellular carcinoma by enhancing SPC24 promoter activity and activating the PI3K-AKT signaling pathway
Huan Yue et al.
CELLULAR ONCOLOGY (2022)
A Novel Cuproptosis-Related Prognostic Gene Signature and Validation of Differential Expression in Clear Cell Renal Cell Carcinoma
Zilong Bian et al.
GENES (2022)
Knockdown of lncRNA FOXD2-AS1 Inhibits Proliferation, Migration, and Drug Resistance of Breast Cancer Cells
Qiaohong Nong et al.
COMPUTATIONAL AND MATHEMATICAL METHODS IN MEDICINE (2021)
Long Noncoding RNA FOXD2-AS1 Promotes Pancreas Adenocarcinoma Cell Invasion and Migration by Sponging miR-30a-3p to Upregulate COX-2
Zhihua Ye et al.
CRITICAL REVIEWS IN EUKARYOTIC GENE EXPRESSION (2021)
Identification and validation of a hypoxia-related prognostic signature in clear cell renal cell carcinoma patients
Zhengtian Li et al.
MEDICINE (2021)
A ten N6-methyladenosine-related long non-coding RNAs signature predicts prognosis of triple-negative breast cancer
Jie Wu et al.
JOURNAL OF CLINICAL LABORATORY ANALYSIS (2021)
Ferroptosis-Related Gene Signature Accurately Predicts Survival Outcomes in Patients With Clear-Cell Renal Cell Carcinoma
Kaili Chang et al.
FRONTIERS IN ONCOLOGY (2021)
m6A-related lncRNAs are potential biomarkers for predicting prognoses and immune responses in patients with LUAD
Feng Xu et al.
MOLECULAR THERAPY-NUCLEIC ACIDS (2021)
Identification and validation of the clinical roles of the VHL-related LncRNAs in clear cell renal cell carcinoma
Wuping Yang et al.
JOURNAL OF CANCER (2021)
Long non-coding RNAs towards precision medicine in gastric cancer: early diagnosis, treatment, and drug resistance
Li Yuan et al.
MOLECULAR CANCER (2020)
Ferroptosis, necroptosis, and pyroptosis in anticancer immunity
Rong Tang et al.
JOURNAL OF HEMATOLOGY & ONCOLOGY (2020)
Immune-Related lncRNA to Construct Novel Signature and Predict the Immune Landscape of Human Hepatocellular Carcinoma
Weifeng Hong et al.
MOLECULAR THERAPY-NUCLEIC ACIDS (2020)
Tumor-Associated Macrophages in Tumor Immunity
Yueyun Pan et al.
FRONTIERS IN IMMUNOLOGY (2020)
Establishment and Validation of a Prognostic Risk Model for Autophagy-Related Genes in Clear Cell Renal Cell Carcinoma
Wenkai Han et al.
DISEASE MARKERS (2020)
Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries (vol 68, pg 394, 2018)
F. Bray et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2020)
The promise of combining cancer vaccine and checkpoint blockade for treating HPV-related cancer
Takeo Shibata et al.
CANCER TREATMENT REVIEWS (2019)
Papillomavirus Immune Evasion Strategies Target the Infected Cell and the Local Immune System
Chenhao Zhou et al.
FRONTIERS IN ONCOLOGY (2019)
Predictors of disease aggressiveness influence outcome from immunotherapy treatment in renal clear cell carcinoma
Yasmin Kamal et al.
ONCOIMMUNOLOGY (2019)
Identification and potential mechanisms of a 4-lncRNA signature that predicts prognosis in patients with laryngeal cancer
Guihai Zhang et al.
HUMAN GENOMICS (2019)
Evaluation of efficacy and safety of sorafenib in kidney cancer patients aged 75 years and older: a propensity score-matched analysis
Katsunori Tatsugami et al.
BRITISH JOURNAL OF CANCER (2018)
Elesclomol restores mitochondrial function in genetic models of copper deficiency
Shivatheja Soma et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2018)
Interleukin-6 induces drug resistance in renal cell carcinoma
Kei Ishibashi et al.
FUKUSHIMA JOURNAL OF MEDICAL SCIENCE (2018)
Sunitinib in kidney cancer: 10 years of experience and development
Elise Nassif et al.
EXPERT REVIEW OF ANTICANCER THERAPY (2017)
Advances in urothelial bladder cancer immunotherapy, dawn of a new age of treatment
Fouad Aoun et al.
IMMUNOTHERAPY (2017)
Exosome-Transmitted lncARSR Promotes Sunitinib Resistance in Renal Cancer by Acting as a Competing Endogenous RNA
Le Qu et al.
CANCER CELL (2016)
Development of immuno-oncology drugs - from CTLA4 to PD1 to the next generations
Axel Hoos
NATURE REVIEWS DRUG DISCOVERY (2016)
LncRNA-RMRP promotes carcinogenesis by acting as a miR-206 sponge and is used as a novel biomarker for gastric cancer
Yongfu Shao et al.
ONCOTARGET (2016)
Long intergenic non-coding RNA 271 is predictive of a poorer prognosis of papillary thyroid cancer
Ben Ma et al.
SCIENTIFIC REPORTS (2016)
Understanding Pathologic Variants of Renal Cell Carcinoma: Distilling Therapeutic Opportunities from Biologic Complexity
Brian Shuch et al.
EUROPEAN UROLOGY (2015)
Copper-Induced Immunotoxicity Involves Cell Cycle Arrest and Cell Death in the Liver
Tarun Keswani et al.
ENVIRONMENTAL TOXICOLOGY (2015)
Multivariate or Multivariable Regression?
Bertha Hidalgo et al.
AMERICAN JOURNAL OF PUBLIC HEALTH (2013)
Integrated molecular analysis of clear-cell renal cell carcinoma
Yusuke Sato et al.
NATURE GENETICS (2013)
The relationship of copper to DNA damage and damage prevention in humans
Maria C. Linder
MUTATION RESEARCH-FUNDAMENTAL AND MOLECULAR MECHANISMS OF MUTAGENESIS (2012)
Copper-induced immunotoxicity involves cell cycle arrest and cell death in the spleen and thymus
Soham Mitra et al.
TOXICOLOGY (2012)
How to build and interpret a nomogram for cancer prognosis
Alexia Iasonos et al.
JOURNAL OF CLINICAL ONCOLOGY (2008)
APTIMA PCA3 molecular urine test: Development of a method to aid in the diagnosis of prostate cancer
Jack Groskopf et al.
CLINICAL CHEMISTRY (2006)